The dramatic liver fat clearance at higher doses strongly suggests proportional visceral fat reduction
GLP-1 receptor agonists are not photosensitizers, and no known interaction exists between these medications and red or near-infrared light at clinical parameters
Heres who might benefit most: People with insulin resistance or metabolic syndrome who have chronically elevated insulin levels that increase the production of artery-damaging cholesterol particles People with fatty liver disease and dyslipidemia (abnormal amount of fats in the blood) who need to lower inflammation and stress on the liver, bringing down high triglycerides and inhibiting production of artery-damaging cholesterol particles People whose blood work shows elevated levels of these biomarkers : ApoB : The total count of all plaque forming particles in the blood
For those who are nursing, whether you can take GLP-1 while breastfeeding is a critical safety consideration
Im an irresponsible drug user, she joked, but Im not gonna take a diabetic drug
Personalized Clinically-proven GLP-1 plans Expert-led education, 10K+ active community Treatment precisely matched to your body & goals Dosing personalized & titrated by your clinician to minimize side effects Unlimited video calls & messaging with your clinician 100% online